Key Insights

Highlights

Success Rate

80% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 37/100

Termination Rate

5.0%

1 terminated out of 20 trials

Success Rate

80.0%

-6.5% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

75%

3 of 4 completed with results

Key Signals

3 with results80% success

Data Visualizations

Phase Distribution

15Total
Not Applicable (9)
P 1 (4)
P 2 (2)

Trial Status

Recruiting7
Active Not Recruiting5
Completed4
Unknown1
Withdrawn1
Not Yet Recruiting1

Trial Success Rate

80.0%

Benchmark: 86.5%

Based on 4 completed trials

Clinical Trials (20)

Showing 20 of 20 trials
NCT04907643Not ApplicableRecruiting

Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes

NCT01815359Phase 2Active Not RecruitingPrimary

ICARuS Post-operative Intraperitoneal Chemotherapy (EPIC) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) After Optimal Cytoreductive Surgery (CRS) for Neoplasms of the Appendix, Colon or Rectum With Isolated Peritoneal Metastasis

NCT06715839Not ApplicableRecruiting

Target-specific immunoPET Imaging of Digestive System Carcinoma

NCT04157322Active Not Recruiting

Plasma 5hmC Signatures as a Marker of Colorectal / Appendiceal Peritoneal Metastasis

NCT04526886Not ApplicableCompleted

Clinical Trial of a Novel Dose Adjustment Algorithm for Preventing Cytopenia-Related Delays During FOLFOX Chemotherapy

NCT05780684Not ApplicableRecruiting

Individualized Dose Escalation of 5-FU for Gastrointestinal Cancer

NCT05277766Phase 1Recruiting

Intraperitoneal Aerosolized Nanoliposomal Irinotecan (Nal-IRI) in Peritoneal Carcinomatosis From Gastrointestinal Cancer

NCT06263088Not ApplicableRecruiting

EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.

NCT05734430RecruitingPrimary

Genetics of Appendix Cancer Study

NCT05623787Not ApplicableActive Not Recruiting

Diagnostic Value of Diffusion-weighted Magnetic Resonance in High-risk Colorectal and Appendiceal Neoplasms

NCT04902872Phase 1Active Not Recruiting

Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors

NCT04028479Completed

The Registry of Oncology Outcomes Associated with Testing and Treatment

NCT06216561Phase 1Withdrawn

Intraperitoneal LSTA1 in CRS-HIPEC

NCT05919758Recruiting

Value of Right-sided Hemicolectomy for Chldren With High-risk Neuroendocrine Tumors of the Appendix

NCT05305820Not ApplicableActive Not Recruiting

Perioperative Exercise and Nutritional Optimisation Prehabilitation Before Surgery for Patients With Peritoneal Malignancy

NCT02489422Not ApplicableCompleted

Programs To Support You During Chemotherapy

NCT03287947Phase 2TerminatedPrimary

LCI-GI-APX-NIN-001: Nintedanib in Metastatic Appendiceal Carcinoma

NCT02833753Phase 1Completed

Trial of Intraperitoneal (IP) Oxaliplatin in Combination With Intravenous FOLFIRI

NCT04634448Not ApplicableNot Yet Recruiting

The Prevalence of Appendiceal Tumours in Periappendicular Abscess

NCT03210298Unknown

International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)

Showing all 20 trials

Research Network

Activity Timeline